Sermorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH) consisting of 29 amino acids. It represents the biologically active fragment of endogenous GHRH and is used in laboratory research focused on growth hormone signaling mechanisms.
In research settings, sermorelin is studied for its interaction with GHRH receptors and downstream endocrine signaling pathways involved in growth hormone release. Due to its unmodified structure and defined peptide sequence, it is commonly used in experimental models examining physiological hormone regulation.
Sermorelin is supplied in lyophilized (freeze-dried) form to preserve molecular stability during storage and transport.
For research purposes only. Not for human consumption.
| Specification |
Detail |
| Compound Name |
Sermorelin |
| Classification |
Synthetic GHRH analogue peptide |
| Peptide Type |
Linear peptide |
| Molecular Formula |
C₁₄₉H₂₄₆N₄₄O₄₂ |
| Molecular Weight |
~3,357.9 g/mol |
| Amino Acid Length |
29 amino acids |
| Purity |
≥99% (HPLC verified) |
| Form |
Lyophilized powder |
| Quantity |
10 mg per vial |
| Solubility |
Soluble in aqueous solutions (research handling) |
| Testing |
HPLC / MS |
| COA |
Available per batch |
| Storage |
Store refrigerated (2–8 °C) or frozen for long-term stability |
| CAS Number |
86168-78-7 |
